StrellaLab Dog Allergy Relief & Anti-Itch Chews bring together ingredients like omega-3 rich fish oil, pumpkin, and digestive enzymes in a small 2-gram bite that dogs can savor daily

Designed for dogs from puppies to seniors, these chews aim to be gentle on sensitive skin while supporting overall wellness

While individual results vary, many pet parents appreciate a tasty daily routine that aligns with their dog’s natural needs

What makes these chews stand out Omega-3 fatty acids from fish oil help support skin and coat health as part of a balanced routine Pumpkin puree and digestive enzymes provide nourishment and may aid digestion-friendly comfort Delicious flavor and aroma that many dogs eagerly accept, turning daily care into a treat Small 2 g chew size designed for easy chewing and swallowing across ages and sizes All-natural ingredients crafted with safety in mind and proudly made in the USA How it could fit into your routine once daily as part of meals or as a rewards treat, with no disruptive routines Subscribe & Save option to ensure your dog runs out of their favorite chews A gentle, pet-friendly formula that complements everyday care without harsh additives In practice, many dogs appear to respond over time with consistent use, commonly noting improvements in coat softness and a calmer skin experience

Some households report changes within 2-3 weeks, while others may take longer depending on the dog’s individual needs

The product is proudly produced in the USA and backed by a 90-day , underscoring a commitment to quality and responsive customer support

Additional benefits to consider Omega-3 fatty acids may support a healthy immune response and overall vitality Natural pumpkin and enzymes contribute to nourishment and nutrient absorption FAQ Q: What benefits can I expect from StrellaLab Dog Allergy Relief Chews

A: A tasty blend with omega-3s, pumpkin, and enzymes to support skin comfort, coat health, and immune balance—results vary

Q: Is this product made in the USA and is there a

A: Yes, made in the USA; backed by a 90-day for risk- trying